CTSK was overexpressed in 53% (8/10) of the CRPC tissues, although the expression of CTSK was only observed in 29% (5/10) of ADPC samples and in 2% (10/10) of BPH samples. This evidence concerns the gene CTSK and benign prostatic hyperplasia.